Nanosphere, Inc. (NSPH)
-NasdaqGM 3.71 
0.01(0.27%) 9:39AM EDT - Nasdaq Real Time Price
| Prev Close: | 3.70 |
|---|
| Open: | N/A |
|---|
| Bid: | 3.60 x 500 |
|---|
| Ask: | 3.79 x 100 |
|---|
| 1y Target Est: | 4.43 |
|---|
| Beta: | 3.67 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 3.69 - 3.71 |
|---|
| 52wk Range: | 1.72 - 4.49 |
|---|
| Volume: | 12,090 |
|---|
| Avg Vol (3m): | 613,284 |
|---|
| Market Cap: | 207.02M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.64 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- As The Patent Cliff Approaches, Buy TrovaGeneat Seeking Alpha(Wed, Jun 5)
- Nanosphere to Present at the Jefferies 2013 Global Healthcare ConferenceMarketwired(Mon, Jun 3)
- Nanosphere coverage assumed with a Buy at Jefferiesat theflyonthewall.com(Fri, May 31)
- NANOSPHERE INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, May 30)
- Bulls On Parade: Is Nanosphere's Bull Run Over?at Seeking Alpha(Tue, May 28)
- Nanosphere's CEO Presents at 2013 UBS Global Healthcare Services Conference (Transcript)at Seeking Alpha(Thu, May 23)
- Nanospheres High Margin Pathogen Identification System Shows Promiseat Seeking Alpha(Wed, May 22)
- New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013Marketwired(Thu, May 16)
- Nanosphere to Present at UBS Global Healthcare ConferenceMarketwired(Wed, May 15)
- NANOSPHERE INC FinancialsEDGAR Online Financials(Tue, May 14)
- Bulls pile into Take-Two InteractiveoptionMONSTER(Tue, May 14)
- BRIEF-Nanosphere shares up 18 pct premarketat Reuters(Tue, May 14)
- Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies CorporationMarketwired(Mon, May 13)
- NANOSPHERE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online(Mon, May 13)
- Nanosphere's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| NSPH | 0.27% | 207.02M |
| BAX | 0.00% | 38.22B |
| COV | 0.00% | 30.82B |
| CSRT.L | 0.57% | 229.71M |
| BDX | 0.00% | 19.41B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 33.58 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.58 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.15 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -0.33 |
|---|
Business Summary
Nanosphere, Inc. develops, manufactures, and markets molecular diagnostics platform, the Verigene System that enables genomic and protein testing on a single platform.
View More